SCHEMBL6205749

SCHEMBL6205749

CCOc1ccc2[nH]cc(C(=O)NCc3cccs3)c(=O)c2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.73
LMNA P02545 3/20 0.73
MAPK1 P28482 1/20 0.73
POLB P06746 5/20 0.72
RAB9A P51151 4/20 0.64
TP53 P04637 4/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
KDM4E B2RXH2 5/20 0.62
HSD17B10 Q99714 5/20 0.57
HPGD P15428 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAPK10 P53779 1/20 0.57
MAPT P10636 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204972 0.84 POLB (1.00) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL6204810 0.83 POLB (0.88) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL6205497 0.82 POLB (0.75) ALDH1A1LMNAMAPK1POLBRAB9A
SCHEMBL6205412 0.82 ALDH1A1 (0.73) ALDH1A1LMNAMAPK1POLBRAB9A
SCHEMBL6204588 0.82 POLB (0.75) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL7740429 0.81 KDM4E (0.78) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL6204573 0.81 RAB9A (0.74) ALDH1A1LMNAMAPK1POLBRAB9A
SCHEMBL6228627 0.81 POLB (0.83) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL6205607 0.80 POLB (0.75) ALDH1A1LMNAPOLBRAB9ATP53
SCHEMBL6227484 0.80 POLB (0.81) ALDH1A1LMNAPOLBRAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US claimed
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP disclosed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed